AstraZeneca starts late-stage trial of key new cancer drug
LONDON - AstraZeneca, which is fighting a $106 billion bid approach from Pfizer, said on Thursday it had launched a final-stage study of a key new lung cancer drug that ...
We value your privacy
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
No cookies to display.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
No cookies to display.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
No cookies to display.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
No cookies to display.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
No cookies to display.
LONDON - AstraZeneca, which is fighting a $106 billion bid approach from Pfizer, said on Thursday it had launched a final-stage study of a key new lung cancer drug that ...
BY ANDREW M. SEAMAN NEW YORK - Despite concerns and some evidence that fertility treatments increase a woman's chances of developing breast cancer, a large, long term study finds no ...
BY BEN HIRSCHLER LONDON - GlaxoSmithKline Plc (GSK) has stopped a high-profile clinical trial using a novel vaccine to fight lung cancer after deciding it will not be possible to ...
Northwest Biotherapeutics Inc on Friday said an independent monitoring board had recommended that a late-stage study of its experimental brain-cancer treatment be continued, based on an interim safety review. The ...
Media error: Format(s) not supported or source(s) not found
Download File: https://sundiatapost.com/wp-content/uploads/2025/01/cbn-gocashless.mp4?_=1